公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2022 | Neoadjuvant afatinib with paclitaxel for triple-negative breast cancer and the molecular characteristics in responders and non-responders | PO-HAN LIN ; Tseng, Ling-Ming; Lee, Yi-Hsuan; Chen, Shou-Tung; Yeh, Dah-Cherng; Dai, Ming-Shen; Liu, Liang-Chih; MING-YANG WANG ; Chiao Lo ; Chang, Stanley; Tan, Kien Thiam; Chen, Shu-Jen; SUNG-HSIN KUO ; CHIUN-SHENG HUANG | Journal of the Formosan Medical Association | 6 | 4 | |
2023 | Radiotherapy versus low-dose tamoxifen following breast-conserving surgery for low-risk and estrogen receptor-positive breast ductal carcinoma in situ: an international open-label randomized non-inferiority trial (TBCC-ARO DCIS Trial) | SUNG-HSIN KUO ; Tseng, Ling-Ming; Chen, Shou-Tung; Sagara, Yasuaki; Chang, Yuan-Ching; Yeh, Hsien-Tang; Kuo, Yao-Lung; Hung, Chih-Chiang; TZU-PIN LU ; Lee, Yi-Hsuan; Toi, Masakazu; CHIUN-SHENG HUANG | BMC cancer | 0 | | |
2015 | Randomized study of tailored neoadjuvant chemotherapy according to the expression of tau, topo II alpha, and ERCC1 versus standard chemotherapy in HER2-negative breast cancer | Lu, Yen-Shen; Yeh, Dah-Cherng; Tseng, Ling-Ming; Chen, Shou-Tung; Lien, Huang-Chun; Chang, Hong-Tai; Chang, Yuan-Ching; Huang, Shu-Min; Lin, Ching-Hung; Cheng, Ann-Lii; Huang, Chiun-Sheng; 鄭安理 | J. Clin. Oncol. | | | |